InsidersTradesSigma
Explore the complete record of transactions filed by BONNEY MICHAEL W, Director. Insider active across 1 companies, notably Bristol Myers Squibb Co. Aggregated, 4 disclosures have been logged. The latest transaction was disclosed on 13 June 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Michael W. Bonney is a Board Member at Bristol Myers Squibb Co. He brings expertise in the pharmaceutical sector, contributing to the governance of the company. His role involves overseeing strategic initiatives and evaluating growth opportunities. Michael plays an important role in guiding the company's decisions regarding treatments and health solutions.